The Canadian STOP-PAIN project - Part 2: What is the cost of pain for patients on waitlists of multidisciplinary pain treatment facilities?

Denise N. Guerriere, Manon Choinière, Dominique Dion, Philip Peng, Emma Stafford-Coyte, Brandon Zagorski, Robert Banner, Pamela M. Barton, Aline Boulanger, Alexander J. Clark, Allan S. Gordon, Marie Claude Guertin, Howard M. Intrater, Sandra M. Lefort, Mary E. Lynch, Dwight E. Moulin, May Ong-Lam, Mélanie Racine, Saifee Rashiq, Yoram ShirPaul Taenzer, Mark Ware

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

77 Citas (Scopus)

Resumen

Purpose: The Canadian STOP-PAIN Project was designed to document the human and economic burden of chronic pain in individuals on waitlists of Multidisciplinary Pain Treatment Facilities (MPTF). This paper describes the societal costs of their pain. Methods: A subgroup of 370 patients was selected randomly from The Canadian STOP-PAIN Project. Participants completed a self-administered costing tool (the Ambulatory and Home Care Record) on a daily basis for three months. They provided information about publicly financed resources, such as health care professional consultations and diagnostic tests as well as privately financed costs, including out-of-pocket expenditures and time devoted to seeking, receiving, and providing care. To determine the cost of care, resources were valued using various costing methods, and multivariate linear regression was used to predict total cost. Results: Overall, the median monthly cost of care was $1,462 (CDN) per study participant. Ninety-five percent of the total expenditures were privately financed. The final regression model consisted of the following determinants: educational level, employment status, province, pain duration, depression, and health-related quality of life. This model accounted for 35% of the variance in total expenditure (P < 0.001). Conclusion: The economic burden of chronic pain is substantial in patients on waitlists of MPTFs. Consequently, it is essential to consider this burden when making decisions regarding resource allocation and waitlist assignment for a MPTF. Resource allocation decision-making should include the economic implications of having patients wait for an assessment and for care.

Idioma originalEnglish
Páginas (desde-hasta)549-558
Número de páginas10
PublicaciónCanadian Journal of Anaesthesia
Volumen57
N.º6
DOI
EstadoPublished - jun. 2010
Publicado de forma externa

Nota bibliográfica

Funding Information:
Funding sources This study was funded by the Canadian Institutes of Health Research/Rx&D Collaborative Research Program (Grant No. DOP 68175) in partnership with Pfizer Canada Inc. Additional funds were obtained from three research networks of Fonds de la recherche en santé du Québec (FRSQ): the Oral Health Research Network, the Neurosciences and Mental Health Research Network, and the Rehabilitation Research Network. Mélanie Racine is a Canadian Institutes of Health Research Strategic Training Fellow in «Pain Research: From Molecules to Community». Pfizer Canada Inc. did not influence the design, conduct, or reporting of the trial in any manner.

ASJC Scopus Subject Areas

  • Anesthesiology and Pain Medicine

Huella

Profundice en los temas de investigación de 'The Canadian STOP-PAIN project - Part 2: What is the cost of pain for patients on waitlists of multidisciplinary pain treatment facilities?'. En conjunto forman una huella única.

Citar esto